Company Ticker News December 19, 2021EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected 0 0 Share
Company Ticker News December 3, 2021Should You Blame Biogen for Medicare Part B Premium Hikes? 0 0 Share
Press Release December 1, 2021Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients 0 0 Share
Press Release December 1, 2021Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD 0 0 Share
Company Ticker News November 30, 2021Is it too late to sell Biogen stock after losing an appeal on its multiple sclerosis drug? 0 0 Share
Company Ticker News November 30, 2021Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg 0 0 Share
Company Ticker News November 17, 2021European Regulator Votes Down Biogen's Alzheimer's Drug 0 0 Share
Company Ticker News November 17, 2021Biogen shares slide 4% after EU advisory committee says it can't agree to endorse company's Alzheimer's disease drug 0 0 Share
Press Release November 17, 2021Update on Regulatory Review of Aducanumab in the European Union 0 0 Share